Expression of mesothelin in thymic carcinoma and its potential therapeutic significance by Thomas, Anish, MD, Chen, Yuanbin, MD PhD, Berman, Arlene, MS, Schrump, David S., MD, Giaccone, Giuseppe, MD PhD, Pastan, Ira, MD, Venzon, David J., PhD, Liewehr, David J., MS, Steinberg, Seth M., PhD, Miettinen, Markku, MD, Hassan, Raffit, MD, Rajan, Arun, MD

Get full text

High-Risk Non-Small Cell Lung Cancer Treated With Active Scanning Proton Beam Radiation Therapy and Immunotherapy by Carrasquilla, Michael, Paudel, Nitika, Collins, Brian T., Anderson, Eric, Krochmal, Rebecca, Margolis, Marc, Balawi, Ahssan, DeBlois, David, Giaccone, Giuseppe, Kim, Chul, Liu, Stephen, Lischalk, Jonathan W.

Get full text

High risk non-small cell lung cancer treated with active scanning proton beam radiotherapy and immunotherapy by Carrasquilla, Michael, MD, Paudel, Nitika, MD PhD, Collins, Brian T., MD, Anderson, Eric, MD, Krochmal, Rebecca, MD, Margolis, Marc, MD, Balawi, Ahssan, DeBlois, David, Giaccone, Giuseppe, MD PhD, Kim, Chul, MD, Liu, Stephen, MD, Lischalk, Jonathan W., MD

Get full text

Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial by Garassino, Marina Chiara, MD, Martelli, Olga, MD, Broggini, Massimo, PhD, Farina, Gabriella, MD, Veronese, Silvio, PhD, Rulli, Eliana, PhD, Bianchi, Filippo, MD, Bettini, Anna, MD, Longo, Flavia, MD, Moscetti, Luca, MD, Tomirotti, Maurizio, MD, Marabese, Mirko, PhD, Ganzinelli, Monica, PhD, Lauricella, Calogero, PhD, Labianca, Roberto, MD, Floriani, Irene, PhD, Giaccone, Giuseppe, MD, Torri, Valter, MD, Scanni, Alberto, MD, Marsoni, Silvia, MD

Get full text

Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study by Giaccone, Giuseppe, Prof, Kim, Chul, MD, Thompson, Jillian, MSN, McGuire, Colleen, MSN, Kallakury, Bhaskar, Prof, Chahine, Joeffrey J, MS, Manning, Maria, MD, Mogg, Robin, PhD, Blumenschein, Wendy M, BA, Tan, Ming T, Prof, Subramaniam, Deepa S, MD, Liu, Stephen V, MD, Kaplan, Ian M, PhD, McCutcheon, Justine N, BS

Get full text

Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial by Thomas, Anish, MD, Rajan, Arun, MD, Berman, Arlene, RN, Tomita, Yusuke, MD, Brzezniak, Christina, MD, Lee, Min-Jung, PhD, Lee, Sunmin, MS, Ling, Alexander, MD, Spittler, Aaron J, RN, Carter, Corey A, MD, Guha, Udayan, MD, Wang, Yisong, PhD, Szabo, Eva, MD, Meltzer, Paul, MD, Steinberg, Seth M, PhD, Trepel, Jane B, Loehrer, Patrick J, Prof, Giaccone, Giuseppe, Prof

Get full text

Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study by Cappuzzo, Federico, Dr, Ciuleanu, Tudor, MD, Stelmakh, Lilia, MD, Cicenas, Saulius, Prof, Szczésna, Aleksandra, MD, Juhász, Erzsébet, MD, Esteban, Emilio, MD, Molinier, Olivier, MD, Brugger, Wolfram, MD, Melezínek, Ivan, MUDr CSc, Klingelschmitt, Gaëlle, MSc, Klughammer, Barbara, PhD, Giaccone, Giuseppe, Prof

Get full text

Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial by Haïk, Stéphane, MD, Marcon, Gabriella, MD, Mallet, Alain, Prof, Tettamanti, Mauro, PhD, Welaratne, Arlette, Giaccone, Giorgio, MD, Azimi, Shohreh, BSc, Pietrini, Vladimiro, MD, Fabreguettes, Jean-Roch, PharmD, Imperiale, Daniele, MD, Cesaro, Pierre, Prof, Buffa, Carlo, MD, Aucan, Christophe, PhD, Lucca, Ugo, MSc, Peckeu, Laurène, MSc, Suardi, Silvia, PhD, Tranchant, Christine, Prof, Zerr, Inga, Prof, Houillier, Caroline, MD, Redaelli, Veronica, MD, Vespignani, Hervé, Prof, Campanella, Angela, BSN, Sellal, François, MD, Krasnianski, Anna, MD, Seilhean, Danielle, Prof, Heinemann, Uta, MD, Sedel, Frédéric, MD, Canovi, Mara, PhD, Gobbi, Marco, PhD, Di Fede, Giuseppe, MD, Laplanche, Jean-Louis, Prof, Pocchiari, Maurizio, MD, Salmona, Mario, PhD, Forloni, Gianluigi, PhD, Brandel, Jean-Philippe, MD, Tagliavini, Fabrizio, Dr

Get full text

Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-... by Demetri, George D, Prof, Reichardt, Peter, Prof, Kang, Yoon-Koo, Prof, Blay, Jean-Yves, Prof, Rutkowski, Piotr, MD, Gelderblom, Hans, MD, Hohenberger, Peter, Prof, Leahy, Michael, FRCP, von Mehren, Margaret, Prof, Joensuu, Heikki, Prof, Badalamenti, Giuseppe, MD, Blackstein, Martin, FRCP, Le Cesne, Axel, MD, Schöffski, Patrick, Prof, Maki, Robert G, Prof, Bauer, Sebastian, MD, Nguyen, Binh Bui, MD, Xu, Jianming, MD, Nishida, Toshirou, MD, Chung, John, MD, Kappeler, Christian, PhD, Kuss, Iris, MD, Laurent, Dirk, MD, Casali, Paolo G, MD

Get full text

Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial by Rajan, Arun, MD, Carter, Corey A, MD, Berman, Arlene, MS, Cao, Liang, PhD, Kelly, Ronan J, MD, Thomas, Anish, MD, Khozin, Sean, MD, Chavez, Ariel Lopez, MD, Bergagnini, Isabella, BA, Scepura, Barbara, CRNP, Szabo, Eva, MD, Lee, Min-Jung, PhD, Trepel, Jane B, Browne, Sarah K, MD, Rosen, Lindsey B, BS, Yu, Yunkai, MS, Steinberg, Seth M, PhD, Chen, Helen X, MD, Riely, Gregory J, MD, Giaccone, Giuseppe, Dr

Get full text